Redx Pharma PLC - ESG Rating & Company Profile powered by AI
The ESG score for Redx Pharma PLC represents its transparency towards the UN Sustainable Development Goals. Check the bottom of the webpage for potential risks for Redx Pharma PLC based on sector, location and marketcap. Complete ESG analysis of Redx Pharma PLC can be accessed by signing in.
Redx Pharma PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 5.3, social score of 4.8 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
| 483 | aTyr Pharma Inc | 6.1 | High |
| 498 | Redx Pharma PLC | 6.0 | High |
| 498 | Cann Group Ltd | 6.0 | High |
| 498 | Biosynex SA | 6.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Redx Pharma PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Redx Pharma PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Redx Pharma PLC report the average age of the workforce?
Sign up for free to unlockDoes Redx Pharma PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Redx Pharma PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Redx Pharma PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Redx Pharma PLC offer flexible work?
Sign up for free to unlockDoes Redx Pharma PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Redx Pharma PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Redx Pharma PLC conduct supply chain audits?
Sign up for free to unlockDoes Redx Pharma PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Redx Pharma PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Redx Pharma PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Redx Pharma PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Redx Pharma PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Redx Pharma PLC disclose water use targets?
Sign up for free to unlockDoes Redx Pharma PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Redx Pharma PLC have a product recall in the last two years?
Sign up for free to unlockDoes Redx Pharma PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Redx Pharma PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Redx Pharma PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Redx Pharma PLC disclose parental leave metrics?
Sign up for free to unlockDoes Redx Pharma PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Redx Pharma PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Redx Pharma PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Redx Pharma PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Redx Pharma PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Redx Pharma PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Redx Pharma PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Redx Pharma PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Redx Pharma PLC disclose its waste policy?
Sign up for free to unlockDoes Redx Pharma PLC report according to TCFD requirements?
Sign up for free to unlockDoes Redx Pharma PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Redx Pharma PLC disclose energy use targets?
Sign up for free to unlockDoes Redx Pharma PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Redx Pharma PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Redx Pharma PLC
These potential risks are based on the size, segment and geographies of the company.
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor for the treatment of fibrotic diseases. In addition, it develops gastrointestinal targeted ROCK inhibitor to treat crohn's disease-associated fibrosis; discoidin domain receptors (DDRs) inhibitor for the treatment of multiple fibrotic conditions; and RXC006, a porcupine inhibitor targeting fibrotic diseases, including idiopathic pulmonary fibrosis. The company has a research collaboration agreement with Jazz Pharmaceuticals plc to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase pathway. Redx Pharma Plc was incorporated in 2010 and is based in Macclesfield, the United Kingdom.